Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors

Rhea-AI Summary

Accuray Incorporated (NASDAQ: ARAY) has appointed Byron C. Scott, M.D., MBA, to its Board of Directors as of February 12, 2021. Dr. Scott is a renowned physician executive with extensive experience in healthcare analytics and technology. Currently, he teaches at the University of Massachusetts and Jefferson University. His previous roles include Deputy Chief Health Officer at IBM Watson Health and leadership positions at Truven Health Analytics and EmCare. The appointment aims to strengthen Accuray's management team amid evolving radiation therapy market demands.

Positive

• Appointment of Byron C. Scott brings significant expertise in healthcare technology and analytics.
• Dr. Scott's background is expected to enhance Accuray's strategic vision and financial objectives.

Negative

• Potential concerns about continuity in leadership due to the new board member's integration process.

SUNNYVALE, Calif., Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott, M.D., MBA to the company's Board of Directors, effective as of February 12, 2021. Dr. Scott brings significant experience as a physician executive with invaluable global expertise in healthcare analytics and technology.

Dr. Scott is currently on the faculties at the University of Massachusetts, Amherst, Isenberg School of Management and Jefferson University, College of Population Health where he teaches healthcare quality, patient safety, and performance improvement. Previously, Dr. Scott served as Deputy Chief Health Officer at IBM Watson Health, where he successfully guided healthcare organizations in the alignment of strategies, quality and performance improvement, and was an industry-recognized thought leader with respect to Watson Health products and services. Dr. Scott also held leadership roles at Truven Health Analytics, a company providing healthcare quality and efficiency solutions using data, analytics, and consulting, prior to its acquisition by IBM. Previous to his tenure at Truven, Dr. Scott held positions of increasing responsibility at EmCare, a hospital-based physician practice management company that was part of Envision Healthcare, including most recently, as Executive Vice President of the West Division.

"We are pleased to welcome Dr. Scott to the Accuray Board and look forward to working with him during this exciting time in the company's evolution. Accuray continues to develop and introduce differentiated solutions to meet the needs of a continually changing radiation therapy market. Dr. Scott's background as a physician and expertise in healthcare technology will enable him to offer a unique and important perspective to our management team," said Joshua H. Levine, President and Chief Executive Officer.

"During my tenure in the healthcare technology arena, I've had the opportunity to work with many senior management teams to successfully accelerate their organization's growth. I joined the Accuray Board because I believe my experience will give me the insights necessary to make a meaningful contribution to the achievement of the company's financial goals. I truly believe in the organization's vision and the potential of its industry-leading radiation therapy solutions," said Byron C. Scott, M.D., MBA.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.

Media Contact:
Beth Kaplan                                                      
Accuray                                                            
+1 (408) 789-4426                                            
bkaplan@accuray.com

Investor Contact
Joe Diaz
Investor Relations - Accuray
Tel: +1 (602) 717-7804
E-mail: jdiaz@accuray.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-appoints-healthcare-executive-and-physician-byron-c-scott-to-board-of-directors-301231609.html

SOURCE Accuray Incorporated

FAQ

Who is Byron C. Scott and what is his role at Accuray?

Byron C. Scott is a physician executive appointed to Accuray's Board of Directors on February 12, 2021, bringing expertise in healthcare technology.

What experience does Byron C. Scott have in the healthcare industry?

Dr. Scott has served as Deputy Chief Health Officer at IBM Watson Health and has held senior positions in Truven Health Analytics and EmCare.

What impact is expected from Byron C. Scott's appointment at Accuray?

Dr. Scott's expertise is anticipated to provide insights that may accelerate Accuray's growth and enhance its performance in the radiation therapy market.